home / stock / lhdx / lhdx news


LHDX News and Press, Lucira Health Inc. From 05/09/22

Stock Information

Company Name: Lucira Health Inc.
Stock Symbol: LHDX
Market: NASDAQ

Menu

LHDX LHDX Quote LHDX Short LHDX News LHDX Articles LHDX Message Board
Get LHDX Alerts

News, Short Squeeze, Breakout and More Instantly...

LHDX - Lucira gets EU clearance to sell both COVID-19 & flu and COVID-19 molecular tests

Lucira Health (NASDAQ:LHDX) on Monday said both its COVID-19 & flu and COVID-19 molecular tests have been cleared for sale and distribution throughout the European Union. Both tests developed by the company run on a palm-sized device with no separate instrument or reader and produce resul...

LHDX - Lucira Receives CE Mark for both COVID-19 & Flu and COVID-19 Molecular Tests

EMERYVILLE, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of innovative infectious disease tests, announced that both its COVID-19 & Flu and COVID-1...

LHDX - Lucira Health to Participate in Bank of America 2022 Healthcare Conference

EMERYVILLE, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced th...

LHDX - Lucira Health to Announce First Quarter 2022 Financial Results

EMERYVILLE, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced ...

LHDX - LUCIRA HEALTH AND USA BOXING ANNOUNCE EXCLUSIVE PARTNERSHIP FOR THE 2022 SEASON

LUCIRA HEALTH AND USA BOXING ANNOUNCE EXCLUSIVE PARTNERSHIP FOR THE 2022 SEASON PR Newswire Lucira is the official COVID-19 test provider of USA Boxing athletes and staff and will commit $5 of support to the organization for each test purchased by fans ...

LHDX - COVID-19 public health emergency extended another 90 days

The COVID-19 public health emergency that was set to expire on April 16 has been extended by 90 days into mid-July by Health and Human Services Secretary Xavier Becerra, Reuters reported. The emergency has required private health insurers to cover to cover the cost of COVID tests and vaccines...

LHDX - Lucira Health Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

EMERYVILLE, Calif., April 11, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that on April 6, 2022, the Board of Directo...

LHDX - Lucira Donates Rapid Molecular At-Home COVID-19 Test Kits to Protect the Safety of Tonga Red Cross Society Workers

Lucira Donates Rapid Molecular At-Home COVID-19 Test Kits to Protect the Safety of Tonga Red Cross Society Workers PR Newswire COVID-19 Comes to Isolated Pacific Island of Tonga And Cases Soar After Volcanic Eruption and Tsunami EMERYVILLE, Calif. , ...

LHDX - Lucira Health's PCR-Quality At-Home COVID-19 Test Now Available Direct to Consumers in Canada

Lucira Health's PCR-Quality At-Home COVID-19 Test Now Available Direct to Consumers in Canada PR Newswire Lucira's molecular test provides PCR-quality results in 30 minutes in a simple single-use test Lucira was the first at-home COVID-19 test authorized in C...

LHDX - Lucira Health, Inc. (LHDX) CEO Erik Engelson on Q4 2021 Results - Earnings Call Transcript

Lucira Health, Inc. (LHDX) Q4 2021 Earnings Conference Call March 10, 2022, 04:30 PM ET Company Participants Greg Chodaczek - Gilmartin Group, IR Erik Engelson - President, CEO Dan George - CFO Conference Call Participants Derik De Bruin - Bank of America Merrill Lynch Griffin Soriano - Willi...

Previous 10 Next 10